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1. Introduction 
Kawasaki disease is an acute childhood systemic vasculitis characterised by a number of 
clinical features, with a predilection for damage to the coronary arteries. It predominantly 
affects children between the ages of 6 months to 4 years, although cases at either extreme of 
childhood are well described and are recognised to be associated with a greater risk of 
delayed diagnosis and treatment (Harnden et al., 2009; Pannaraj et al., 2004). There is a male 
predominance with a male to female ratio of 1.6 to 1. Despite important research progress 
since its first description in 1967 (Kawasaki, 1967), the aetiology remains unknown and there 
is no diagnostic test. The timely use of intravenous immunoglobulin has reduced the 
incidence of coronary artery lesions from 25% to 2-4% (Newburger et al., 2004). 
Transthoracic echocardiography is recommended in suspected cases of KD, however a 
normal study does not exclude the diagnosis.  
2. Incidence 
Kawasaki disease is the most common cause of paediatric acquired heart disease (Taubert et 
al., 1991). The incidence has been rising in both developed (Japan, Korea and United 
Kingdom) and rapidly industrialising countries such as India, which may reflect both a 
genuine increase and increased recognition (Krishnakumar & Mathews, 2006). The highest 
annual incidence is reported in Japan (218 per 100000 children <5 years of age) and Korea 
(113 per 100000 <5 years) (Nakamura et al., 2010; Park et al., 2011). The incidence is lower in 
Australia (3.7 per 100000 <5 years) but this data is 15 years old (Royle et al., 1998); given the 
rising incidence in other countries these rates may be an underestimate of true disease 
burden. Current epidemiological research is in progress in Western Australia, and these 
data will provide an updated incidence for Australia children.  
3. Aetiology  
The high incidence of Kawasaki disease in Asian populations and increased risk in families 
and siblings suggests a genetic predisposition (Fujita et al., 1989; Uehara et al., 2003). 
Seasonal patterns are well recognised, with peaks in winter and spring in Australia, the 
United States and Europe and spring to summer peaks in Korea and China (Burgner & 
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Harnden, 2005). The epidemiology of Kawasaki disease, clustering of cases, community 
outbreaks and epidemics in the 1980s, support the hypothesis that an unknown infectious 
agent (or agents) triggers an abnormal inflammatory response in genetically susceptible 
individuals. Both conventional antigens and bacterial superantigens have been implicated as 
causative triggers in Kawasaki disease, however the triggering pathogen(s) remain 
unknown. 
4. Pathogenesis 
Initially, activated inflammatory cells, particularly monocytes, macrophages, T-cells, and 
subsequently platelets, adhere to the endothelial cells that line medium-size elastic arteries. 
Other mediators contribute to destruction of the extra-cellular matrix, leading to vessel 
dilatation, and subsequent smooth muscle proliferation in the media contributes to later 
pathology. There is destruction of the intimal layer of the affected artery with inflammatory 
infiltrate during the acute phase, and histologic findings of myocarditis and fibrosis are 
found in virtually all cases with Kawasaki disease (Yutani et al., 1981). 
5. Clinical assessment 
The typical presentation is of an irritable child who has an unremitting high fever (often 
>39C) for 5 or more days, and some or all classical diagnostic of the clinical features (Table 1). 
The diagnosis can also be made by experienced clinicians on the fourth day of fever if classical 
diagnostic criteria are met.1 In most children the clinical features appear sequentially. Specific 
features for KD include perineal desquamation and erythema or crusting around the Bacille 
Calmette Guerin (BCG) inoculation site. Other extracardiac features such as respiratory or 
gastrointestinal symptoms occur frequently and make the diagnosis difficult. 
 
 
The diagnosis requires the presence of fever for at least 5 days, and at least four of the 
following five criteria: 
 
- Polymorphous rash 
- Oral mucous membrane involvement, including red fissured lips, strawberry tongue 
or injected pharynx 
- Bilateral non-exudative conjunctivitis 
- Changes with extremities including erythema or oedema of palms and soles, or 
periungal desquamation as a late sign in the subacute phase (~2 or more weeks after 
illness onset) 
- Cervical lymphadenopathy, defined as a unilateral lymph node of ≥1.5cm 
 
Table 1. The diagnostic criteria for Kawasaki disease (Newburger et al. 2004)  
Incomplete KD should be considered in children who have an unexplained prolonged 
febrile illness and have not met diagnostic criteria (Newburger et al., 2004). This occurs 
more commonly in children less than 6 months or greater than 5 years of age, with the 
younger age group more likely to present with fewer clinical features and also a higher 
incidence of coronary artery abnormalities (Genizi et al., 2003). 
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Kawasaki disease shock syndrome has been recently described and is characterised by 
hypotension and haemodynamic instability, often requiring intensive care. (Dominguez et 
al., 2008; Yim et al., 2010) These patients may be at increased risk of delayed diagnosis and 
treatment, refractory disease and more severe coronary artery involvement (Kanegaye et al., 
2009). 
6. Echocardiography in Kawasaki disease 
Transthoracic echocardiography is highly sensitive and specific for the diagnosis of 
coronary artery involvement and should be performed in confirmed or suspected cases of 
Kawasaki disease at the time of diagnosis. It is important to ensure that the timing or 
results of the echocardiogram do not delay initial treatment of Kawasaki disease, and that 
the diagnosis is made predominantly on clinical findings. On the other hand, if full 
criteria are not met and coronary artery abnormalities are present on echocardiography, 
then the child has incomplete features of Kawasaki disease and treatment with high dose 
intravenous immunoglobulin should be considered. The American Heart Association 
consensus guidelines provide a schema for the incorporation of echocardiography into the 
diagnostic process in children with possible incomplete Kawasaki disease (Newburger et 
al., 2004). 
7. Principles of echocardiographic assessment 
7.1 Optimisation of imaging modalities 
The primary aim of echocardiography is to identify coronary artery involvement, 
pericarditis and/or myocarditis. As always, optimising machine settings, using the highest 
possible frequency transducer and reducing two-dimensional gain and compression can 
achieve better image quality and resolution. B-mode cine loops and still frame images are 
necessary to assess coronary artery calibre, along with colour Doppler imaging set at a low 
Nyquist limit for evaluating normal coronary artery diastolic flow. Sedation may be 
necessary in children who are too irritable to tolerate a detailed study; our preference is to 
use 50-100mg/kg of chloral hydrate (max 1g) given orally with heart rate and peripheral 
oxygen saturation monitoring.  
7.2 Coronary artery assessment  
Coronary arteries should be assessed in multiple imaging planes before a decision is 
reached about the presence or absence of coronary artery abnormalities. The parasternal 
short axis view with or without a clockwise rotation of the transducer allows for imaging of 
the left coronary artery origin, left anterior descending artery and left circumflex artery, as 
well as the right coronary artery origin and proximal course. Parasternal long axis views 
with sweeps between the aorta and pulmonary artery will delineate the left main coronary 
artery, left anterior descending and circumflex arteries. Subcostal views are helpful for 
assessing the left circumflex artery and the mid-course of the right coronary artery. Apical 
four chamber views will show the length of the left circumflex artery and distal right 
coronary artery in the left and right atrioventricular grooves respectively. Coronary artery 
measurements should be taken from the inner edge to inner edge of the vessel wall and 
should not be measured at the level of normal branching. 
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8. Cardiovascular involvement 
8.1 Coronary artery involvement 
The main features of coronary artery involvement are dilatation, aneurysm formation, lack 
of tapering of the distal coronary vessel and perivascular brightness. Aneurysms may be 
fusiform (spindle-shaped, gradual tapering from normal to dilated segment), saccular 
(spherical, acute transition from normal to dilated segment), ectatic (uniformly dilated long 
segment) or segmented (multiple dilatations joined by normal or stenotic areas) (Figure 1). 
The common sites of coronary involvement (from highest to lowest frequency) include the 
proximal left anterior descending artery (Figure 2), proximal right coronary artery (Figure 3 
& 4), left main coronary artery (Figure 5), left circumflex branch (Figure 5), distal right 
coronary artery (Figure 6) and the junction of the right and posterior descending coronary 
artery. Takahashi et al reported that aneurysms were more likely to resolve if they were 
fusiform in nature and if the child was female and/or less than a year of age. Distal 
coronary artery aneurysms tended to regress more rapidly than aneurysms located in 





Fig. 1. Illustrative example of coronary artery abnormalities.  
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Fig. 2. Parasternal short axis echocardiographic image at the level of the mitral valve leaflets 
demonstrating an aneurysm of the left anterior descending artery.  
 
Fig. 3. Parasternal short axis echocardiographic image showing a uniformly dilated 
proximal right coronary artery (RCA). 
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Fig. 4. Parasternal short axis image showing a giant aneurysm of the right coronary artery 
(RCA). 
 
Fig. 5. Parasternal short axis view showing a uniformly dilated left main coronary artery 
(LMCA, 4.7mm) and dilated circumflex artery (Cx, 3.4mm). Ao = aorta 
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Fig. 6. Off-axis parasternal short axis view demonstrating a fusiform aneurysm of the mid to 
distal right coronary artery (RCA) aneurysm  
8.2 Myo-pericarditis 
Virtually all patients with Kawasaki disease develop myocarditis to varying degrees 
during the acute phase, and over half of these patients develop acute transient left 
ventricular dysfunction (Ajami et al., 2010). Systolic left ventricular function should be 
routinely assessed. Regional wall motion abnormalities may occur if there is significant 
coronary artery involvement. Pericarditis may be reflected by the presence of a pericardial 
effusion. 
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8.3 Valvar involvement 
Myocardial inflammation may also involve valve tissue and lead to mitral, tricuspid or 
aortic regurgitation that is usually mild in nature. If severe mitral regurgitation is present, 
papillary muscle dysfunction and myocardial ischaemia should be assessed (Akagi et al., 
1990). Mild aortic regurgitation is seen to persist in approximately 4% of patients with serial 
follow-up (Ravekes et al., 2001). Aortic root dilatation may occur as part of the overall 
vasculitis but is usually mild. 
9. Timing of echocardiography 
The consensus statement from the American Heart Association recommends performing 
echocardiography at diagnosis, 2 weeks and repeating at 6-8 weeks after the onset of illness 
for uncomplicated cases. In some centres the 2 week echocardiogram is not routinely 
performed. The imaging at diagnosis should provide a baseline study for serial follow-up of 
left ventricular function, coronary arterial involvement, valvar regurgitation, myocarditis 
and/or a pericardial effusion. The presence of any cardiac involvement warrants closer follow-
up. In particular, coronary aneurysms > 5mm in size require close monitoring because of an 
elevated risk of developing stenotic lesions within the vessel (Mueller, 2009). By 6-8 weeks, 
transient cardiac involvement is likely to have resolved, or if coronary artery dilation and/or 
aneurysms are present, the maximum diameter is usually reached by this time.  
10. Definitions of coronary artery involvement 
A number of definitions have been proposed to describe and quantitate coronary artery 
involvement. The Japanese Ministry of Health classification was first published in 1984. 
Aneurysms are considered to be small if their internal diameter is <5mm, medium if 
between 5-8mm, or giant if the internal diameter of the aneurysm is >8mm (Figure 5). These 
criteria are widely used and define absolute values for coronary artery dimensions and 
therefore do not account for differences in patient size or the usual caliber of different 
coronary artery branches. The American Heart Association AHA guidelines were published 
in 2004 and define coronary artery dimensions with respect to body surface area, which 
requires both weight and height measurements. These define a coronary artery as dilated if 
the intra-luminal diameter has a z-score of ≥ 2.5mm. Manlhiot et al. recently proposed a 
revision of this classification to account for differences in body size and caliber of coronary 
artery branches, and report that coronary artery abnormalities are small if the z-score is ≥ 2.5 
to <5, large if the z-score is ≥ 5 to < 10, and giant if the z-score is ≥ 10 (Manlhiot et al., 2010). 
This method is however prone to significant variation in the calculated z-score with minor 
variation in measurement of coronary size. It is therefore too early to determine whether this 
classification will be widely employed. 
11. Further imaging modalities 
As the difficulty of coronary artery imaging increases with age, further imaging options may 
be necessary. Even in experienced hands, echocardiography also has its limitations in 
detecting stenosis and thrombosis. The efficacy of other non-invasive imaging modalities 
such as magnetic resonance imaging and multi-detector computed tomography has been 
increasingly evaluated for coronary artery assessment in Kawasaki disease (Figure 7).  
www.intechopen.com








Fig. 7. Magnetic resonance image using T2 weighted truFISP sequence demonstrating a 
dilated left anterior descending (LAD) artery with a distal fusiform aneurysm.  
12. Functional assessment 
Cardiac stress testing may be used to identify reversible ischaemia and regional wall 
motion abnormalities during increased demand. Coronary perfusion abnormalities can be 
further assessed with exercise echocardiography, pharmacologic (dobutamine, 
dipyridamole or adenosine) stress echocardiography and exercise myocardial perfusion 
scans. The stress modality employed depends on the age of the child and local expertise, 
although practically speaking, pharmacologic stress echocardiography or exercise 
myocardial perfusion scans are the preferred techniques in the paediatric age group. If 
abnormalities of coronary segmental perfusion are found, the results may assist decision-
making for further management.  
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13. Cardiac catheterisation 
Cardiac catheterisation with selective coronary angiography is considered the gold standard 
for delineation of coronary artery anatomy, and if required interventional procedures such 
balloon angioplasty, stent placement or percutaneous transluminal coronary 
revascularisation may be performed in the same setting. Cardiac catheterisation is generally 
not recommended for patients with mild coronary artery involvement, however it can 
provide useful detailed information and help with risk stratification of patients who have 
complex coronary artery lesions (Figure 8 & 9). Coronary angiography in this instance is 








Fig. 8. Lateral selective coronary angiogram demonstrating a significantly dilated left 
anterior descending (LAD) artery and proximal circumflex (Cx) artery. 
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Fig. 9. Lateral angiographic plane with injection of contrast in the ascending aorta via a pigtail 
catheter, showing large saccular aneurysms in both the proximal right and left coronary 
arteries. (Image courtesy of Professor Mike South, Royal Children’s Hopsital, Melbourne) 
14. Natural history  
The percentage of patients developing coronary aneurysms is reduced with timely 
administration of intravenous immunoglobulin. Nearly 50% of those coronary artery 
aneurysms will show angiographic regression within 1 to 2 years following the illness, 
with smaller lesions having a greater chance of resolution (Newburger et al., 2004). The 
size of the aneurysm is a major predictor for the development of myocardial infarction 
(Yeu et al., 2008). As aneurysms remodel with time, however, the risk of coronary artery 
stenosis increases.  
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There is evidence that Kawasaki disease in childhood may increase the risk of 
cardiovascular disease in adulthood. Patients with coronary artery aneurysms have an 
increase in carotid artery intima-media thickness, and increased systemic arterial stiffness 
with higher pulse wave velocities (Cheung et al., 2007; Ooyanagi et al., 2004; Suzuki et al., 
1996). Furthermore there are data demonstrating abnormal vascular endothelial function 
and lipid profiles in patients. The exact level of increased risk is uncertain. 
15. Follow-up recommendations  
Patients with Kawasaki disease should be followed up based on risk stratification according 
to the severity of coronary artery involvement in consultation with a paediatric cardiologist 
familiar with managing the condition.  
 
 
 Kawasaki disease is a common childhood systemic vasculitis characterized by 
specific clinical features and persistent fever for at least 5 days. 
 
 Transthoracic echocardiography is recommended in suspected cases of Kawasaki 
disease, however a normal study does not exclude the diagnosis.  
 
 Treatment with high dose intravenous immunoglobulin should be initiated based 
on the clinical presentation, and should not be delayed by the timing of 
echocardiography. 
 
 The aims of echocardiography are to identify coronary artery dilatation and 
aneurysms, valvar regurgitation, myocarditis with ventricular dysfunction and 
pericarditis with effusion. 
 
 Echocardiography should be performed at diagnosis, and approximately 6-8 weeks 
after the onset of illness, with more frequent assessments required if cardiac 
involvement is present.  
 
Table 2. Kawasaki disease - Summary points  
16. Conclusion 
In summary, Kawasaki disease is an important and common systemic vasculitis of 
childhood, and the advent of intravenous immunoglobulin has significantly reduced, but 
not removed the risk of abnormal coronary artery development in affected individuals. 
There have been significant advances in our overall understanding of the condition, 
although the aetiology remains uncertain. Of concern is the emerging evidence that KD is a 
risk factor for adult coronary artery disease. Further research into pathogenesis and long 
term outcomes are required. 
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